Cargando…
FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice
BACKGROUND: Over the last decade, an increasing number of studies have been published on the use of amyloid-β (Aβ) PET imaging with different (18)F-radiopharmaceuticals for clinical characterization of Alzheimer’s disease (AD) in different stages. However, distinct study cohorts and different quanti...
Autores principales: | Yousefi, Behrooz H, von Reutern, Boris, Scherübl, Daniela, Manook, André, Schwaiger, Markus, Grimmer, Timo, Henriksen, Gjermund, Förster, Stefan, Drzezga, Alexander, Wester, Hans-Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402683/ https://www.ncbi.nlm.nih.gov/pubmed/25918674 http://dx.doi.org/10.1186/s13550-015-0090-6 |
Ejemplares similares
-
Correction: (18)F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases
por: Grimmer, Timo, et al.
Publicado: (2018) -
Small-Animal PET Imaging of Amyloid-Beta Plaques with [(11)C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease
por: Manook, André, et al.
Publicado: (2012) -
Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012) -
Beta-amyloid imaging with florbetaben
por: Sabri, Osama, et al.
Publicado: (2015) -
LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo
por: Grimmer, Timo, et al.
Publicado: (2014)